Log in to search using one of your social media accounts:

 

Inspire Puts Sluggish IPO Concerns to Bed with Filing
Inspire Medical Systems is seeking to raise about $75 million through an initial public offering. The company said the IPO was for 5 million shares of its common stock and the price is expected to be between $14 and $16 per share. Inspire has been approved to list its common stock on the New York Stock Exchange under the ticker symbol “INSP.” The Minneapolis-based company has developed a neurostimulation device that provides treatment for moderate-to-severe obstructive sleep apnea (OSA). The technology is a closed-loop solution that uses an algorithm to continuously monitor a patient’s breathing patterns ...
Source: MDDI - April 25, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Implants Source Type: news

Medical Marijuana May Not Help Your Sleep Apnea
In the United States, nearly 30 million adults are affected by sleep apnea. This condition occurs when the upper airway repeatedly collapses during sleep, resulting in snoring and daytime sleepiness. (Source: WebMD Health)
Source: WebMD Health - April 25, 2018 Category: Consumer Health News Source Type: news

Medtronic spinout Inspire Medical sets range for $75m IPO
Inspire Medical Systems this week set the range for a proposed initial public offering that would fetch $75 million at the midpoint. Maple Grove, Minn.-based Inspire, which spun out from Medtronic (NYSE:MDT) in 2007, makes devices for treating obstructive sleep apnea. The company said it plans to issue 5 million shares at $14 to $16 apiece, setting its market capitalization at roughly $305 million. Inspire, which posted net losses of -$17.5 million on sales of $28.6 million last year, plans to list on the New York Stock Exchange under the INSP symbol. The flotation is slated to price next week. The company d...
Source: Mass Device - April 25, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Initial Public Offering (IPO) Respiratory Wall Street Beat Inspire Medical Systems Inc. Medtronic Source Type: news

Medical Marijuana May Not Help Your Sleep Apnea
In the United States, nearly 30 million adults are affected by sleep apnea. This condition occurs when the upper airway repeatedly collapses during sleep, resulting in snoring and daytime sleepiness. (Source: WebMD Health)
Source: WebMD Health - April 25, 2018 Category: Consumer Health News Source Type: news

Medical Marijuana May Not Help Your Sleep Apnea: Experts
Title: Medical Marijuana May Not Help Your Sleep Apnea: ExpertsCategory: Health NewsCreated: 4/24/2018 12:00:00 AMLast Editorial Review: 4/25/2018 12:00:00 AM (Source: MedicineNet Sleep General)
Source: MedicineNet Sleep General - April 25, 2018 Category: Sleep Medicine Source Type: news

ResMed Succeeds with Tech, Then Hires a CTO
One of medtech’s most connected health technology companies has just hired its first chief technology officer. Sleep apnea device manufacturer ResMed credits its remote sleep-monitoring patient platform, AirView, with downloading more than 1 billion nights of sleep data. Patients can use the company’s smartphone app myAir to access their information. The company also crows about how those technologies combined with its CPAP machines and updated masks improve patient compliance with the therapy and the likelihood of that therapy being covered by insurance. How did it do all this without a CTO? Raj Sodhi, preside...
Source: MDDI - April 25, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Digital Health Source Type: news

Medical Marijuana May Not Help Your Sleep Apnea: Experts
TUESDAY, April 24, 2018 -- Medical marijuana shouldn't be used to treat sleep apnea, the American Academy of Sleep Medicine says in a new position statement. The group warned that the drug and its synthetic extracts haven't been shown to be safe,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 24, 2018 Category: General Medicine Source Type: news

Medical Cannabis Not Recommended for Sleep Apnea
FRIDAY, April 20, 2018 -- Medical cannabis and/or its synthetic extracts should not be used for treating patients with obstructive sleep apnea (OSA), according to an American Academy of Sleep Medicine position statement published in the April 15... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 20, 2018 Category: Pharmaceuticals Source Type: news

Apr 20, 2018 This Week in Cardiology Apr 20, 2018 This Week in Cardiology
Ambulatory BP measurements, advanced practice providers, medical marijuana for sleep apnea, Barbara Bush's comfort care, and apixaban for cardioversion are the topics discussed in this week's podcast.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 20, 2018 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news

Vasomotor Symptoms and Sleep Apnea Risk in Midlife Women Vasomotor Symptoms and Sleep Apnea Risk in Midlife Women
Are menopausal vasomotor symptoms associated with increased risk of obstructive sleep apnea, independent of obesity?Menopause (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 20, 2018 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news

Don't Use Medical Marijuana for Sleep Apnea, AASM Warns Don't Use Medical Marijuana for Sleep Apnea, AASM Warns
Medical cannabis and synthetic marijuana extracts should not be used to treat obstructive sleep apnea, the American Academy of Sleep Medicine says in a new position statement.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 19, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Sleep Group Opposes Medical Cannabis for Sleep Apnea
(MedPage Today) -- AASM cites insufficient evidence of efficacy, safety (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - April 16, 2018 Category: Psychiatry Source Type: news

Position statement: Avoid using medical marijuana to treat sleep apnea
(American Academy of Sleep Medicine) Medical cannabis and synthetic marijuana extracts should not be used for the treatment of obstructive sleep apnea, according to a position statement from the American Academy of Sleep Medicine (AASM). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 16, 2018 Category: International Medicine & Public Health Source Type: news

Breath-taking research: Throat reflexes differ in people with tetraplegia and sleep apnea
(The Physiological Society) New research published in The Journal of Physiology has indicated why people with paralysis of their limbs and torso are more likely to suffer from sleep apnea. This knowledge could be used to develop much-need targeted therapies. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 15, 2018 Category: Biology Source Type: news

Contextualizing naturalistic driving data in a rural state among drivers with and without obstructive sleep apnea - Dawson JD, Bair E, Askan N, Sewell K, Tippin J, Rizzo M.
In naturalistic studies, Global Positioning System (GPS) data and date/time stamps can link driver exposure to specific environments (e.g., road types, speed limits, night driving, etc.), providing valuable context for analyzing critical events, such as cr... (Source: SafetyLit)
Source: SafetyLit - April 12, 2018 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

Sleep Apnea Makes For More Crash-Prone Drivers
Among those who don't suffer from sleep apnea but only get six hours of rest a night, the risk of a crash is 33 percent higher than if they sleep eight hours every night, the researchers added. (Source: WebMD Health)
Source: WebMD Health - April 12, 2018 Category: Consumer Health News Source Type: news

Even When You Think You're Not Sleepy, Your Car Crash Risk Rises
WEDNESDAY, April 11, 2018 -- You might be a drowsy driver without knowing it, and new research finds that can make you more dangerous on the road. People who suffer from chronic sleep apnea are more likely to crash, the study showed: For those with... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 11, 2018 Category: General Medicine Source Type: news

Sleep Deficiency Leads to Higher Number of Motor Vehicle Crashes
WEDNESDAY, April 11, 2018 -- Sleep deficiency due to sleep apnea or sleep duration less than seven hours is associated with motor vehicle crashes independent of self-reported excessive sleepiness, according to a study published online March 20 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 11, 2018 Category: Pharmaceuticals Source Type: news

Inspire Medical plans $86m IPO
Inspire Medical Systems, which spun out from Medtronic (NYSE:MDT) in 2007 and creates devices for treating obstructive sleep apnea, said last Friday it is looking to launch an initial public offering that could bring in as much as $86.3 million for the company. Inspire Medical developed and produces a sleep apnea implant, a pacemaker-like system designed to stimulate nerves to keep airways open during sleep. The Minneapolis-based company said it plans to offer shares under the NYSE ticker symbol “INSP”. Last year, the company reported sales of $28.6 million and approximately $22.6 in gross profit, wit...
Source: Mass Device - April 9, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Initial Public Offering (IPO) Respiratory Inspire Medical Systems Inc. Source Type: news

Sunrise Labs executes succession plan | Personnel Moves – April 5, 2018
Medical device and life science development group Sunrise Labs said this week that it completed its succession plan, with president Eric Soederberg acquiring the majority of shares in the company through a stock sale with founder and board chair Drew Sunstein. With the transaction, the Bedford, N.H.-based company said that it secured its planned ownership succession, and added that founder Sunstein will retain a minority stock position in the company and will remain active within it. Details of the transaction were not disclosed. Soederberg joined Sunrise in 2008, and prior to joining served as a programs executive directo...
Source: Mass Device - April 5, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Wall Street Beat Abbott AdvaMed Alere Brightree Celgene cerevasc Cohera Medical Inc. Digirad Corp. IlluminOss Medical Inc. johnsonandjohnson K2M ResMed Inc. Smith & Nephew Stryker Sunrise Labs Vasc Source Type: news

Gore Takes on Abbott with New PFO Stroke Indication
W.L. Gore & Associates has received FDA approval to expand the indication of the Gore Cardioform Septal Occluder to reduce the risk of recurrent ischemic stroke in patients. The device treats patients through the closure of patent foramen ovale (PFO). Cardioform’s previous indication was for the closure of atrial septal defects that are up to 17mm in size. Gore’s Structural Heart Leader, Jake Goble said Cardioform has the potential to redefine stroke prevention. Goble began working for Gore in 2007. It was around that time the company began to explore the possibility of having the Cardioform focus on stroke...
Source: MDDI - April 3, 2018 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Source Type: news

ResMed is disrupting connected health: Here ’ s how
The AirMini, the smallest PAP available, was released by ResMed in 2017. [Image courtesy of ResMed] Here’s how a respiratory firm took control of the connected health and the medtech digital revolution. When you think powerful digital connected devices, the first thing to pop into your head probably isn’t a CPAP. Continuous positive airway pressure has been shown in numerous studies to be effective in improving sleep apnea and preventing a host of co-morbidities such as obesity, congestive heart failure and chronic obstructive pulmonary disease. But the buy-in from patients is notoriously lacking. Respiratory ...
Source: Mass Device - April 3, 2018 Category: Medical Devices Authors: Heather Thompson Tags: Big Data Business/Financial News mHealth (Mobile Health) News Well Patient Monitoring connected medical devices Digital Health ResMed Inc. Source Type: news

Prevalence of obstructive sleep apnea syndrome among holders of a category B driver's license and among professionals in the Province of Pesaro-Urbino (Italy) - Vittoria E, Sisti D, Pascucci P, Carlotti E, Cappelli G, Grossi P.
Obstructive Sleep Apnea Syndrome (OSAS) is a sleeping disorder caused by repeated episodes of partial or complete obstruction of the upper airways during sleep. During 2013, a pilot project was performed in the Marche region (Italy), co-jointly by the Univ... (Source: SafetyLit)
Source: SafetyLit - March 26, 2018 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

Sleep deficiency and motor vehicle crash risk in the general population: a prospective cohort study - Gottlieb DJ, Ellenbogen JM, Bianchi MT, Czeisler CA.
BACKGROUND: Insufficient sleep duration and obstructive sleep apnea, two common causes of sleep deficiency in adults, can result in excessive sleepiness, a well-recognized cause of motor vehicle crashes, although their contribution to crash risk in the gen... (Source: SafetyLit)
Source: SafetyLit - March 26, 2018 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

Reduced Cortical Thickness ID ’ d in Obstructive Sleep Apnea
Female OSA patients had multiple regions of reduced cortical thickness in superior frontal lobe (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - March 16, 2018 Category: Respiratory Medicine Tags: Internal Medicine, Neurology, Pathology, Pulmonology, Radiology, Journal, Source Type: news

#DidYouKnow- March 16th is World Sleep Day. According to the American Sleep Association, Obstructive Sleep Apnea affects almost 29 million Americans. Click the link for more information https://aasm.org/about/patient-info/   … #MedicalDevice #FunFactFridaypic.twitter.com/vfBz8mPHAz
#DidYouKnow- March 16th is World Sleep Day. According to the American Sleep Association, Obstructive Sleep Apnea affects almost 29 million Americans. Click the link for more information https://aasm.org/about/patient-info/ … #MedicalDevice #FunFactFriday pic.twitter.com/vfBz8mPHAz (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - March 16, 2018 Category: Medical Devices Authors: ( at FDADeviceInfo) Source Type: news

Sleep apnea study finds male-female differences in cerebral cortex thickness, symptoms
FINDINGSResearchers from the UCLA School of Nursing examined clinical records and magnetic resonance imaging brain scans of patients who were recently diagnosed with sleep apnea, and discovered several apparent connections between thinning of the brain ’s cerebral cortex and apnea symptoms. The researchers also could discern distinct changes in brain structures and concurrent symptoms that differed between men and women. For example, more regions of the superior frontal lobe were thinner in women with apnea than men or control groups, which migh t explain enhanced cognitive deficits among women with the disorder. No ...
Source: UCLA Newsroom: Health Sciences - March 12, 2018 Category: Universities & Medical Training Source Type: news

Do you know the difference between snoring and sleep apnea?
While people with sleep apnea snore, both terms do not describe the same thing. Snoring is just snoring. Sleeping is when your breathing is interrupted while you sleep. Its a very dangerous condition. There are people who snore and its completely harmless. One way to figure out if you suffer from sleep apnea is to quantify how tired you feel after a full nights sleep. People who have sleep apnea tend to feel tired even though they just woke up from what should have been a great nights sleep. Another common sign is if you wake up with a scratchy throat. If you know a loved one who snores at night, encourage them to get thei...
Source: Support for International Change : HIV AIDS - March 12, 2018 Category: International Medicine & Public Health Authors: admin Tags: Uncategorized Source Type: news

Obstructive sleep apnea severity is directly related to suicidal ideation in posttraumatic stress disorder - Gupta MA, Jarosz P.
STUDY OBJECTIVES: Posttraumatic stress disorder (PTSD) is associated with suicidal ideation (SI) and obstructive sleep apnea (OSA). There are no studies of OSA diagnosed by sleep study and SI in patients with PTSD. METHODS: Forty consenting civilia... (Source: SafetyLit)
Source: SafetyLit - March 9, 2018 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

Severe Sleep Apnea During REM Sleep Tied to Acute CV Events
Findings among those with apnea during REM sleep and with preexisting cardiovascular disease (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - March 8, 2018 Category: Respiratory Medicine Tags: Cardiology, Pulmonology, Journal, Source Type: news

Rural claim lines with sleep apnea diagnoses increased 911 percent from 2014 to 2017
(FAIR Health) From 2014 to 2017, private insurance claim lines with a diagnosis of sleep apnea -- a potentially serious disorder in which a person repeatedly stops and starts breathing while asleep -- increased by 911 percent in rural America, according to FAIR Health. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 6, 2018 Category: International Medicine & Public Health Source Type: news

7 medtech stories we missed this week: March 2, 2018
[Image from unsplash.com]From InspireMD’s new distribution deals to Kelynium’s distribution deal with a mystery partner, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. InspireMD inks distribution deals in Greece, Caribbean InspireMD announced in a March 1 press release that it has signed exclusive distribution agreements with T-Vascular IKE Medical Supplies in Greece and Endo-Serv, SRL in the Caribbean. Both suppliers create high-tech medical devices for minimally-invasive procedures. Endo-Serv markets to the Dominican Republic, Jamaica, Aruba, Curacao and Tr...
Source: Mass Device - March 2, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Dental Diagnostics Food & Drug Administration (FDA) Hospital Care Imaging Patient Monitoring Regulatory/Compliance Ultrasound Biolase dexalytic Getinge Hologic Inc. iCad Inc. InspireMD Kelyniam Global Inc. MedTech Source Type: news

Jazz Pharmaceuticals Announces FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
DUBLIN, March 2, 2018 -- (Healthcare Sales & Marketing Network) -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing with standard review the company's New Drug Application (ND... Biopharmaceuticals, FDA Jazz Pharmaceuticals, solriamfetol, narcolepsy, obstructive sleep apnea (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 2, 2018 Category: Pharmaceuticals Source Type: news

Jazz Pharmaceuticals Announces FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
DUBLIN, March 2, 2018 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing with standard review the company's New Drug Application (NDA) seeking marketing... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - March 2, 2018 Category: Drugs & Pharmacology Source Type: news

Skip CPAP? Apnea Patients May Return To Hospital
The study involved 345 patients with severe sleep apnea who had been hospitalized at a VA medical center  any time from 2007 to 2015. Most were men over age 62. (Source: WebMD Health)
Source: WebMD Health - March 1, 2018 Category: Consumer Health News Source Type: news

Skipping CPAP May Mean Return to the Hospital for Apnea Patients
THURSDAY, March 1, 2018 -- If people with sleep apnea who've been hospitalized for any reason don't use their breathing treatments when they return home, they're much more likely to end up back in the hospital. They were 3.5 times more likely to be... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 1, 2018 Category: General Medicine Source Type: news

Perioperative Hypoxemic Events in Patients With Sleep Apnea Perioperative Hypoxemic Events in Patients With Sleep Apnea
This study compared two regimens generally considered suitable for OSA patients.BMC Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 1, 2018 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

LivaNova shares up on topped Q4, 2017 earnings
Shares in LivaNova (NSDQ:LIVN) rose today after the medical device maker met most of the expectations on Wall Street with its fourth quarter and full fiscal year 2017 earnings results. The London-based company posted losses of $111.7 million, or $2.32 per share, on sales of $278.4 million for the 3 months ended December 31, seeing losses grow 61.5% while sales grew 11.5% compared with the same period during the previous year. After adjusting to exclude one-time items, earnings per share were 89¢, just ahead of the 77¢ consensus on Wall Street where analysts were expecting to see sales of $262.7 million. For ...
Source: Mass Device - February 28, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat LivaNova Source Type: news

BP Drops in Many Apneic Hypertensive Kids After Adenotonsillectomy BP Drops in Many Apneic Hypertensive Kids After Adenotonsillectomy
Many hypertensive children with obstructive sleep apnea (OSA) who undergo adenotonsillectomy see a reduction in blood pressure (BP), according to researchers in Taiwan.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 26, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Study points to risk of future sleep breathing problems in college football players
(University of North Carolina at Charlotte) Previous studies with older NFL football players have found a high incidence of sleep apnea, a serious health issue, among the group, particularly among older linemen. Now, a study with college-age linemen suggests that the roots of this health problem in football players may begin much earlier, and at an age when the condition is much less likely to occur in the general population. Body training specific to linemen appears to be related. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 21, 2018 Category: International Medicine & Public Health Source Type: news

Determinants of sleepiness in obstructive sleep apnea - Prasad B, Steffen AD, Van Dongen HPA, Pack FM, Strakovsky I, Staley B, Dinges DF, Maislin G, Pack AI, Weaver TE.
STUDY OBJECTIVES: Significant interindividual variability in sleepiness is observed in clinical populations with obstructive sleep apnea (OSA). This phenomenon is only partially explained by the apnea-hypopnea index (AHI). Understanding factors that lead t... (Source: SafetyLit)
Source: SafetyLit - February 19, 2018 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

Bring down the cost of medical care and cure diseases
At the time of this article its 2018. Its hard to believe that people are still dying from some very simple diseases. While medical care has improved, the cost of providing it has skyrocketed. We must all work together and figure out ways to cure people from chronic diseases like AIDs and HIV. Through scientific research and other forms of testing we are getting closer every day to finding a real cure. This is one step in the right direction. Once this cure is found with need to be ready for a solution to take this treatment and provide to the low income and poverty stricken individuals. There are other pretty common medic...
Source: Support for International Change : HIV AIDS - February 16, 2018 Category: International Medicine & Public Health Authors: admin Tags: Uncategorized Source Type: news

NIH-funded researchers identify risk factors for sleep apnea during pregnancy
Snoring, older age and obesity may increase a pregnant woman ’s risk. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - February 13, 2018 Category: American Health Source Type: news

NIH-funded researchers identify risk factors for sleep apnea during pregnancy
(NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development) Snoring, older age and obesity may increase a pregnant woman's risk for sleep apnea -- or interrupted breathing during sleep -- according to researchers funded by the National Institutes of Health. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 13, 2018 Category: International Medicine & Public Health Source Type: news

Neuromodulation 2.0: Enabling the Next Generation of Device-Based Therapies for Treating Chronic Diseases
The neuromodulation device industry is enjoying a period of tremendous growth and diversification. A 2016 article by Neurotech Reports estimated the global market for neurotechnology products to be $7.6 billion predicted it will hit $12 billion by 2020. Neuromodulation devices such as neurostimulators targeting the brain, vagus nerve, and spinal cord account for the largest segment and represent some of the most mature applications of neurotechnology for treating diseases such as movement disorders, epilepsy, and pain. However, there are new neuromodulation devices under development aimed at less traditional applicati...
Source: MDDI - February 6, 2018 Category: Medical Devices Authors: Douglas Weber Tags: Electronics Source Type: news

InVivo Therapeutics lifts Toselli to permanent prez, CEO | Personnel Moves February 6, 2018
InVivo Therapeutics (NSDQ:NVIV) said yesterday it made Dr. Richard Toselli’s spot in the corner office permanent, lifting him from acting CEO to prez and CEO. Dr. Toselli will maintain his position on the company’s board and as its chief medical officer, the position he was given when he joined the company last July. Prior to joining InVivo, Toselli has held positions with Sanofi (NYSE:SNY), DePuy and Johnson & Johnson (NYSE:JNJ). “I am delighted to announce Rich’s full-time role as CEO. Rich has demonstrated clear vision, a strategic mind, and committed leadership in his time at ...
Source: Mass Device - February 6, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Alcon Baxter Boston Scientific Faxitron GE Healthcare InVivo Therapeutics johnsonandjohnson Lima Corporate Luxottica Medizone Medtronic performancehealth Respicardia Robocath Sanofi-Aventis T2 Biosys Source Type: news

Sleep Apnea Might Put CABG Patients at Risk for Ventricular Arrhythmias Sleep Apnea Might Put CABG Patients at Risk for Ventricular Arrhythmias
Sleep-disordered breathing (SDB) is associated with abnormal cardiac repolarization before coronary artery bypass graft surgery (CABG), according to new research.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 5, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

LivaNova wins CE Mark for PureFlex arterial cannulae
LivaNova (NSDQ:LIVN) said yesterday it won CE Mark approval in the European Union for its PureFlex line of adult arterial cannulae. The newly cleared PureFlex cannulae are designed with curved and straight tip options and feature phthalate-free flexible tubing and a wire-reinforcement spring, the London-based company said. “Our decades-long commitment to excellence in cannulation continues with the addition of the new PureFlex cannulae to our robust portfolio. We call it ‘the cannulae that can. Now with CE Mark, we are eager to offer this high-quality line of cannulae to cardiac surgery teams and skilled s...
Source: Mass Device - February 2, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Regulatory/Compliance LivaNova Source Type: news

Respicardia launches Remed ē system, taps Sommerness as CEO
Respicardia said today it launched its Remedē transvenous implantable neurostimulation system designed to treat patients with central sleep apnea, and that it named Peter Sommerness as CEO. The Remedē system consists of a surgically placed battery pack and thin wires inserted into the blood vessels in the chest near the phrenic nerve, which it stimulates to engage the diaphragm to restore natural breathing during sleep and improve patient quality of life and satisfaction. “Central sleep apnea is very common in cardiac patients, especially patients with heart failure, and is associated with a significantly grea...
Source: Mass Device - February 2, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Neuromodulation/Neurostimulation Respiratory Respicardia Source Type: news

Non - Sleep Specialists May Offer Similar Quality Sleep Apnea Care
Findings based on review comparing OSA care by non - sleep specialists vs. sleep specialist physicians (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - January 31, 2018 Category: Respiratory Medicine Tags: Family Medicine, Internal Medicine, Neurology, Pulmonology, Journal, Source Type: news